Literature DB >> 10203321

Cerebrospinal fluid nitric oxide metabolites in painful diseases.

S Kimura1, K Watanabe, Y Yajiri, T Motegi, Y Masuya, K Shibuki, S Uchiyama, T Homma, H E Takahashi.   

Abstract

To elucidate the involvement of NO in pain transmission in humans, we measured NO metabolites (nitrite/nitrate) in the CSF of patients with painful diseases using an NO analyzer based on the Griess method. The nitrite/nitrate levels in patients with degenerative lumbar disease (DLD), but not those with fracture or appendicitis, were significantly higher than those in an age-matched control group. The duration of pain in the DLD group was much longer than that in the fracture or appendicitis group. The nitrite/nitrate levels in the middle-aged and elderly DLD patients depended on the duration of pain. These data probably suggest that the duration of pain is critical for the elevation in nitrite/nitrate levels.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10203321     DOI: 10.1097/00001756-199902050-00013

Source DB:  PubMed          Journal:  Neuroreport        ISSN: 0959-4965            Impact factor:   1.837


  7 in total

Review 1.  The role of nitric oxide in nociception.

Authors:  Z D Luo; D Cizkova
Journal:  Curr Rev Pain       Date:  2000

Review 2.  Inflammatory mechanisms in cervicogenic headache: an integrative view.

Authors:  Paolo Martelletti
Journal:  Curr Pain Headache Rep       Date:  2002-08

3.  Clinical significance of cerebrospinal fluid nitric oxide concentrations in degenerative cervical and lumbar diseases.

Authors:  Hiroshi Denda; Shinji Kimura; Akiyoshi Yamazaki; Noboru Hosaka; Yuichi Takano; Kenji Imura; Yoichi Yajiri; Naoto Endo
Journal:  Eur Spine J       Date:  2010-12-29       Impact factor: 3.134

4.  Significant correlation between cerebrospinal fluid nitric oxide concentrations and neurologic prognosis in incomplete cervical cord injury.

Authors:  Noboru Hosaka; Shinji Kimura; Akiyoshi Yamazaki; Xianjun Wang; Hiroshi Denda; Takui Ito; Toru Hirano; Naoto Endo
Journal:  Eur Spine J       Date:  2007-08-22       Impact factor: 3.134

5.  Nitric Oxide Metabolite Concentration in Cerebrospinal Fluid: Useful as a Prognostic Marker?

Authors:  Saurabh Singh; Jyoti Prakash; Rakesh Singh; Ashish Verma; Hemant Bansal
Journal:  Asian Spine J       Date:  2016-10-17

6.  Affective dimensions of pain and region -specific involvement of nitric oxide in the development of empathic hyperalgesia.

Authors:  Fatemeh Mohammadi; Kristi Anne Kohlmeier; Sajad Jeddi; Meysam Ahmadi-Zeidabadi; Mohammad Shabani
Journal:  Sci Rep       Date:  2020-06-23       Impact factor: 4.379

7.  Ginsenoside Rd inhibits the expressions of iNOS and COX-2 by suppressing NF-κB in LPS-stimulated RAW264.7 cells and mouse liver.

Authors:  Dae Hyun Kim; Jae Heun Chung; Ji Sung Yoon; Young Mi Ha; Sungjin Bae; Eun Kyeong Lee; Kyung Jin Jung; Min Sun Kim; You Jung Kim; Mi Kyung Kim; Hae Young Chung
Journal:  J Ginseng Res       Date:  2013-03       Impact factor: 6.060

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.